Compare SCI & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCI | EXAS |
|---|---|---|
| Founded | 1962 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.3B | 11.0B |
| IPO Year | N/A | N/A |
| Metric | SCI | EXAS |
|---|---|---|
| Price | $76.01 | $101.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 20 |
| Target Price | ★ $92.00 | $76.38 |
| AVG Volume (30 Days) | 812.5K | ★ 10.3M |
| Earning Date | 10-29-2025 | 11-03-2025 |
| Dividend Yield | ★ 1.69% | N/A |
| EPS Growth | ★ 8.17 | N/A |
| EPS | ★ 3.71 | N/A |
| Revenue | ★ $4,290,729,999.00 | $3,082,033,000.00 |
| Revenue This Year | $4.08 | $19.40 |
| Revenue Next Year | $3.47 | $13.51 |
| P/E Ratio | $20.44 | ★ N/A |
| Revenue Growth | 3.41 | ★ 14.47 |
| 52 Week Low | $71.75 | $38.81 |
| 52 Week High | $88.07 | $101.87 |
| Indicator | SCI | EXAS |
|---|---|---|
| Relative Strength Index (RSI) | 33.68 | 89.74 |
| Support Level | $76.64 | $100.98 |
| Resistance Level | $79.81 | $101.43 |
| Average True Range (ATR) | 1.40 | 2.25 |
| MACD | -0.30 | 0.53 |
| Stochastic Oscillator | 9.54 | 97.74 |
Service Corp International is a personal services company that provides funeral and cemetery services and products from its locations throughout the United States and Canada. The company segments its operations into funeral service and cemetery business functions. At its funeral service locations, Service Corp. provides all professional services, facilities, vehicles, and merchandise related to funerals and cremations. Cemetery locations provide cemetery property, memorial markers, and graveyard services to customers. Service Corp. derives the majority of its revenue from its funeral services segment. Geographically, the company derives a majority of its revenue from the United States.
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.